Back to Latest News
Micropore Technologies has just announced the appointment of the Mutual Corporation as the representative for sales of its patented membrane technology in the Japanese market
Established for over 70 years, headquartered in Osaka and with offices/production and research facilities in Fukuoka, Shizuoka, Tokyo, Toyama and Yachimata, the Mutual Corporation designs, manufactures, imports and exports manufacturing equipment with a strong focus on the pharmaceutical and cosmetic sectors.
Mutual Corporation is very well connected throughout Micropore’s target market sectors. Throughout the history of the company, Mutual has aimed to contribute to the development of society by applying the motto “coexistence and mutual prosperity.” Based on the spirit of mutuality, Mutual endeavours to strive for a prosperous future together with its business partners, shareholders and employees.
Together Mutual Corporation and Micropore will serve the parentral drug, vaccine and gene therapy markets as well as the personal care and other demanding market sectors.
Mutual offers comprehensive support for production systems and solutions installed in facilities such as pharmaceuticals, cosmetics, foods and so on through expertise in four market sectors – engineering, manufacturing, trading, maintenance.
We are delighted that Mutual Corporation will help us enter the challenging Japanese market. They bring a wealth of expertise and knowledge and I look forward to our partnership developing positively.
Dai Hayward, Micropore CEO
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Ask An ExpertKeep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.